Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity

Dezhi Sui, Xueying Tang, Junqiang Ding, Yang Wang, Ying Qin, Ning Zhang, Xinrong Liu, Yihui Deng, Yanzhi Song